Bootstrapped since 2008, Evidence Partners closes $20 million to tackle automated literature review market
Evidence Partners caters to more than 60% of the world’s largest pharma, medical device companies.
Evidence Partners caters to more than 60% of the world’s largest pharma, medical device companies.
Plus: Layoffs across SaaS startups pile up.
Plus: Kirk Simpson, Peter Carrescia team up with an idea to disrupt the digital identity space.
Plus: Sandpiper Ventures closes $20 million first fund focused on early-stage, women-led tech startups.
When the party winds down, the hangover is fast to follow.
Article and Mejuri have cut their workforces by 17 and 10 percent, respectively.
Plus: Could the Theranos that was promised come from Sudbury?
CEO: “There’s just a level of uncertainty right across the board.”
Unbounce CEO said cuts were necessary to support the company’s purpose and strategy.
Plus: Caisse needs to explain its risky bet on crypto lender Celsius.
Plus: Our podcast was nominated for an award.
All bets are off.
Clearco called the cuts “necessary” and “prudent.”
The cuts follow hiring sprees that took place across the crypto space last year.
The results come one day after a 10 percent, company-wide reduction in staff.